Search

Your search keyword '"Bordignon Claudio"' showing total 221 results

Search Constraints

Start Over You searched for: Author "Bordignon Claudio" Remove constraint Author: "Bordignon Claudio" Publication Type Magazines Remove constraint Publication Type: Magazines
221 results on '"Bordignon Claudio"'

Search Results

1. Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial

2. R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-a in primary CNS lymphoma

3. R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma

4. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

5. Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation

6. CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma

7. The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils

8. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors

9. T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation

10. IL-7 receptor expression identifies suicide gene–modified allospecific CD8+T cells capable of self-renewal and differentiation into antileukemia effectors

11. IL-7 receptor expression identifies suicide gene–modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors

12. 2D TR‐NOESY Experiments Interrogate and Rank Ligand–Receptor Interactions in Living Human Cancer Cells

13. 2D TRNOESY Experiments Interrogate and Rank Ligand–Receptor Interactions in Living Human Cancer CellsThis work was supported in part by a research grant from the Italian Ministry of Research FIRB. We thank Dr. Angelo Corti for critical reading of the manuscript and Renato Longhi for peptide synthesis.

14. Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients

15. IL-7 and IL-15 allow the generation of suicide gene–modified alloreactive self-renewing central memory human T lymphocytes

16. Temporal, quantitative, and functional characteristics of single-KIR–positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation

17. Selected natural and synthetic retinoids impair CCR7‐ and CXCR4‐dependent cell migration in vitro and in vivo

18. Changes in the Immune Responses Against Human Herpesvirus-8 in the Disease Course of Posttransplant Kaposi Sarcoma

19. Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients

20. The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies

21. Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation

22. Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)–deficient mice and corrects their immune and metabolic defects

23. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes

24. Mobilized Blood CD34+ Cells Transduced and Selected with a Clinically Applicable Protocol Reconstitute Lymphopoiesis in SCID-Hu Mice

25. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation

26. Gene therapy for adenosine deaminase deficiency

27. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence

28. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell–depleted stem cell transplantation

29. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines

30. Absence of Metabolic Cross-correction in Tay-Sachs Cells

31. Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

32. Various Cells Retrovirally Transduced with N-Acetylgalactosoamine-6-Sulfate Sulfatase Correct Morquio Skin Fibroblasts In Vitro

33. A Novel Human Packaging Cell Line with Hematopoietic Supportive Capacity Increases Gene Transfer into Early Hematopoietic Progenitors

34. Peripheral blood stem cell allograft rejection mediated by CD4+ T lymphocytes recognizing a single mismatch at HLA-DPβ1*0901

35. Peripheral blood stem cell allograft rejection mediated by CD4+T lymphocytes recognizing a single mismatch at HLA-DPβ1*0901

36. Optimisation of retroviral supernatant production conditions for the genetic modification of human CD34<SUP>+</SUP> cells

37. A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

38. Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells

39. Human CD34+ Cells Express CXCR4 and Its Ligand Stromal Cell–Derived Factor-1. Implications for Infection by T-Cell Tropic Human Immunodeficiency Virus

40. Restoration of Bacterial Killing Activity of Human Respiratory Cystic Fibrosis Cells through Cationic Vector-Mediated Cystic Fibrosis Transmembrane Conductance Regulator Gene Transfer

41. Reversal of Diabetes in Mice by Implantation of Human Fibroblasts Genetically Engineered to Release Mature Human Insulin

42. Human proinsulin production in primary rat hepatocytes after retroviral vector gene transfer

43. 35th Annual Meeting of the European Association for the Study of Diabetes

44. Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lymphohematopoietic progenitors

45. Human CD34+Cells Express CXCR4 and Its Ligand Stromal Cell–Derived Factor-1. Implications for Infection by T-Cell Tropic Human Immunodeficiency Virus

46. Anti-Leukemia Potential of Interleukin-2 Activated Natural Killer Cells After Bone Marrow Transplantation for Chronic Myelogenous Leukemia

48. Graft Failure After T-Cell-Depleted Human Leukocyte Antigen Identical Marrow Transplants for Leukemia: II. In Vitro Analyses of Host Effector Mechanisms

49. Graft Failure After T-Cell-Depleted Human Leukocyte Antigen Identical Marrow Transplants for Leukemia: I. Analysis of Risk Factors and Results of Secondary Transplants

50. Transduced Fibroblasts and Metachromatic Leukodystrophy Lymphocytes Transfer Arylsulfatase A to Myelinating Glia and Deficient Cells In Vitro

Catalog

Books, media, physical & digital resources